Floatz logo

Vesanoid

Myeloid Malignancy

Ascentage Pharma Group Inc.Phase 3Active
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
53/ 100
Competitive Position
89/ 100

Competitive context

16 Active assets in the Myeloid Malignancy cohort.

Asset / SponsorPhaseRating
Venetoclax
First Affiliated Hospital of Zhejiang University
Phase 3BB
ETOPOSIDE
University of California, San Francisco
Phase 3BB
Arsenic Trioxide
Ruijin Hospital
Phase 3BB
Decitabine
Benjamin Tomlinson
Phase 2BB
DEXAMETHASONE
Ascentage Pharma Group Inc.
Phase 3BB

View all 22 →

Same molecule, other indications

Vesanoid is also rated in:

acute promyelocytic leukemiaDormant
A
Indicative ·
82 / 100
View asset →
acute myeloid leukemiaDormant
BB
Indicative ·
70 / 100
View asset →
myelodysplastic/myeloproliferative neoplasmDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →